Compound Profile: Tretiheal 0.025% Cream Healing Pharma
Tretiheal 0.025% Cream is a topical retinoid formulation containing tretinoin as the active pharmaceutical ingredient. Tretinoin is a vitamin A derivative classified as a first-generation retinoid, widely utilised in dermatological research for its effects on cellular differentiation and proliferation pathways. This formulation from Healing Pharma provides researchers with a standardised concentration for investigating retinoid mechanisms in cellular models. The cream base allows for uniform distribution and controlled exposure conditions in laboratory settings.
Research Applications
Research teams investigating dermatological pathways frequently examine tretinoin formulations for their modulation of gene expression related to keratinocyte differentiation. Studies focus on the compound’s interaction with retinoic acid receptors (RARα, RARβ, RARγ) and retinoid X receptors, which regulate transcription factors involved in cellular turnover. Laboratory investigations explore tretinoin’s effects on comedogenesis pathways, inflammatory mediator expression, and collagen synthesis in cell culture models. Researchers at Stroid UK Shop have access to comprehensive research compounds including SARMs and peptides alongside dermatological compounds like this tretinoin formulation. Research applications include studying retinoid tolerance mechanisms, photoaging prevention pathways, and combination therapy effects with other dermatological agents.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Tretinoin 0.025% |
| Manufacturer | Healing Pharma |
| Formulation | Topical cream |
| CAS Number | 302-79-4 |
| Molecular Formula | C₂₀H₂₈O₂ |
| Molecular Weight | 300.44 g/mol |
| Storage Requirements | Room temperature, protect from light |
Research Compliance
Tretiheal 0.025% Cream is supplied strictly for in-vitro research purposes only and is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Research teams must follow appropriate institutional guidelines and safety protocols when handling retinoid compounds. This product is designed for qualified researchers investigating dermatological pathways, cellular differentiation mechanisms, and retinoid pharmacology in academic or commercial research facilities.
